Genetyczne aspekty wysiłku fizycznego.
Sanocka D, Kurpisz M;
W: Medycyna sportowa, Agencja Wydawnicza Medsportpress, ISBN 83-908701, Warszawa, 2004: 133-143.
Publikacje
Publikacje pracowników w ePub
Konsultacja naukowa i przedmowa: W świecie ADHD. Nadpobudliwość psychoruchowa z zaburzeniami uwagi u dzieci i dorosłych (Hallowell EM, Ratey JJ).
Witt M;
Media Rodzina, Poznań, 2004, ISBN 83-7278-111-7.
Glucokinase mutations in women with gestational diabetes mellitus selected by MODY criteria.
Żurawek M, Wender-Ożegowska E, Januszkiewicz-Lewandowska D, Zawiejska A, Nowak J;
W: XIX European Congress of Perinatal Medicine, Athens, Greece, ed. by A. antsaklism Medimond International Proceedings, 2004: 341-345.
Alteration in phase I and phase II enzyme activities and polycyclic aromatic hydrocarbons: DNA adduct formation by plant phenolics in mouse epidermis.
Szaefer H, Cichocki M, Brauze D, Baer-Dubowska W;
Nutr Cancer, 2004, 48 (1): 70-77.
Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history.
Marcolino I, Przybylski GK, Koschella M, Schmidt ChA, Voehringer D, Schlesier M, Pirscher H;
Eur J Immunol, 2004, 34: 2672-2680.
Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H: quinine oxireductase in beta-naphthoflavone-treated rat.
Brauze D;
Toxicol Lett, 2004, 152: 111-116.
Monosomy 1p36 breakpoints indicate repetitive DNA sequence elements may be involved in generating and/or stabilizing some terminal deletions.
Ballif BC, Gajęcka M, Shaffer LG;
Chromosome Res, 2004, 12: 133-141.
DNAI1 and DNAH5 and primary ciliary dyskinesia or Kartagener syndrome.
Witt M;
In: Inborn errors of development. the molecular basis of clinical disorders of morphogenesis (eds. Ch.J. Epstein, R.P. Erickson, A. Wynshaw-Boris), Oxford monographs on medical genetics, no 49, Oxford University Press, 2004: 934-945.
Autologous skeletal myoblasts transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up.
Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kurpisz M;
American Heart Association, 2004, 148: 531-537.
Increased cancer risk of heterozygotes with NSB1 germline mutations in Poland.
Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidziński M, Gawrychowski K, Sperling K;
Int J Cancer, 2004, 111: 67-71.